Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT02708095

Public ClinicalTrials.gov record NCT02708095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as baricitinib in participants with systemic lupus erythematosus.

Study identification

NCT ID
NCT02708095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
314 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2016 (Actual)
Primary completion
Oct 12, 2017 (Actual)
Completion
Nov 9, 2017 (Actual)
Last update posted
Nov 21, 2018

2016 – 2017

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724 —
Wallace Rheumatic Study Center Beverly Hills California 90211 —
Medvin Clinical Research Covina California 91723 —
TriWest Research Assocaites El Cajon California 92020 —
University of California La Jolla California 92037 —
Desert Medical Advances Palm Desert California 92260 —
Inlande Rheumatology Clinical Trials Upland California 91786 —
Denver Arthritis Center Denver Colorado 80230 —
New Horizon Research Center Miami Florida 33175 —
West Broward Rheumatology Associates, Inc Tamarac Florida 33321 —
Clinical Research of West Florida, Inc. Tampa Florida 33603 —
Kansas City Internal Medicine Research Overland Park Kansas 66209 —
The Arthritis & Diabetes Clinic Inc. Monroe Louisiana 71203 —
Louisiana State University Health Sciences Center Shreveport Louisiana 71103 —
University of Michigan Ann Arbor Michigan 48109 —
Clayton Medical Research St Louis Missouri 63117 —
Arthritis Consultants St Louis Missouri 63141 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
North Shore University Hospital at Great Neck Great Neck New York 11021 —
The Ohio State University Columbus Ohio 43203 —
Paramount Medical Research Middleburg Heights Ohio 44130 —
Arthritis & Rheumatology Center of Oklahoma PLLC Oklahoma City Oklahoma 73103 —
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104-5046 —
The Oklahoma Center For Arthritis Therapy Tulsa Oklahoma 74104 —
East Penn Rheumatology Bethlehem Pennsylvania 18015 —
Clinical Research Center of Reading, LLC Wyomissing Pennsylvania 19610 —
Accent Clinical Research Professionals, LLC Allen Texas 75013 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02708095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02708095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →